Species |
Human |
Protein Construction |
GARP & Latent TGF beta 1 Complex [His20-Leu628 (GARP) and Leu30-Ser390 (Latent TGF beta 1)] Accession # Q14392 (GARP) & P01137 (Latent TGF beta 1) |
His |
Avi |
N-term |
|
C-term |
|
Conjugate |
Biotin |
Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Measured by its binding ability in a functional ELISA. Immobilized AntiGARP&Latent TGF beta 1 Antibody, hFc Tag at 5μg/ml (100μl/well) on the plate can bind GARP&Latent TGF beta 1 Complex[Biotin], His & Avi, Human. Test result was comparable to standard batch. |
Expression System |
HEK293 |
Theoretical Molecular Weight |
70.3 kDa (GARP) and 41.4 kDa (Latent TGF beta 1) |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 73-78 kDa (GARP) and 13 kDa and 42-45 kDa (Latent TGF beta 1) based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Target Background |
GARP&Latent TGF Beta is a complex found on surface of many types of cells. In Tregs, GARP is involved in TCR-mediated activation of Latent TGF-β and thus promoting secretion and activation of TGF-β. Integrin αvβ8 on the surface of immune cells and other cells recognizes RGD in LAP, resulting in the release of mature TGF-β from the TGF-β&GARP complex. |
Synonyms |
LRRC32; GARP; LAP; TGF-beta-1; LRRC32&TGF-beta 1; LRRC32&TGFB1; TGF-β-1; LRRC32&TGF-β 1; GARP&Latent TGF Beta; GARP&Latent TGF Beta 1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.